Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Regulus Therapeutics
(NQ:
RGLS
)
1.620
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
93
Open
1.620
Bid (Size)
1.560 (3)
Ask (Size)
1.620 (4)
Prev. Close
1.620
Today's Range
1.620 - 1.620
52wk Range
1.080 - 3.790
Shares Outstanding
87,040,335
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q2 2024
August 09, 2024
RGLS stock results show that Regulus Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Ball To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Tuesday
June 25, 2024
Via
Benzinga
Performance
YTD
+23.66%
+23.66%
1 Month
+2.53%
+2.53%
3 Month
-35.71%
-35.71%
6 Month
-35.20%
-35.20%
1 Year
-1.82%
-1.82%
More News
Read More
What's Going On With Regulus Therapeutics Stock Monday?
June 24, 2024
Via
Benzinga
RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q1 2024
May 09, 2024
Via
InvestorPlace
The $5 Phenoms: 3 Cheap Stocks That Could Skyrocket by 2028
May 07, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
May 06, 2024
Via
Benzinga
Analyst Expectations for Regulus Therapeutics's Future
September 21, 2023
Via
Benzinga
Expert Ratings for Regulus Therapeutics
June 28, 2023
Via
Benzinga
RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q4 2023
March 21, 2024
Via
InvestorPlace
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 14, 2024
Via
Benzinga
Emerging Companies: Key Developments and Investment Insights RGLS, INBS, VTAK, DYAI, TCBP
March 13, 2024
Via
AB Newswire
Gold Down Over 1%; ClearOne Shares Spike Higher
March 12, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 12, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 12, 2024
Via
Benzinga
Nasdaq Surges Over 1%; Blade Air Mobility Shares Plummet
March 12, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Regulus Therapeutics Inc. (NASDAQ: RGLS) is One of Tuesday Morning’s Most Active Stocks
March 12, 2024
Via
Investor Brand Network
Dow Gains 100 Points; US Inflation Rate Rises To 3.2% In February
March 12, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 12, 2024
Via
Benzinga
Why Is Kidney Disease-Focused Regulus Therapeutics Stock Trading Higher On Tuesday?
March 12, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
March 12, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
September 21, 2023
Via
Benzinga
Regulus Therapeutics Releases Early Data From Of Investigational For Rare Type Of Kidney Disease
September 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 17, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.